RE: Wow!30 Dec 2024 19:11
TheoremRx Signs LOI for Strategic Transaction with NASDAQ-Listed Company, Advancing De-Risked Oncology and Women’s Health Clinical Programs.
NEW YORK CITY, NY, UNITED STATES, December 30, 2024 /EINPresswire.com/ -- TheoremRx Inc. (“TheoremRx”), a private biotechnology company focused on the development of new treatments for patients suffering from cancer and women’s health conditions, announced today that TheoremRx has signed a letter of intent dated December 23, 2024, with respect to a proposed transaction with a NASDAQ listed company.